Stock of the Day: Institutional Investors Positive on Biolife Solutions Inc (NASDAQ:BLFS)

November 21, 2016 - By Winifred Garcia   ·   0 Comments

Stock of the Day: Institutional Investors  Positive on Biolife Solutions Inc (NASDAQ:BLFS)

Sentiment for Biolife Solutions Inc (NASDAQ:BLFS)

Biolife Solutions Inc (NASDAQ:BLFS) institutional sentiment decreased to 1.5 in 2016 Q2. Its down -0.17, from 1.67 in 2016Q1. The ratio is negative, as 5 active investment managers started new and increased positions, while 3 sold and trimmed equity positions in Biolife Solutions Inc. The active investment managers in our partner’s database now have: 377,414 shares, up from 356,666 shares in 2016Q1. Also, the number of active investment managers holding Biolife Solutions Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 3 Reduced: 0 Increased: 3 New Position: 2.

BioLife Solutions, Inc. is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The company has a market cap of $19.96 million. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products. It currently has negative earnings.

The stock closed at $1.55 during the last session. It is down 18.42% since April 19, 2016 and is downtrending. It has underperformed by 22.28% the S&P500.

According to Zacks Investment Research, “BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today.”

Perkins Capital Management Inc holds 0.02% of its portfolio in BioLife Solutions Inc for 10,000 shares. Two Sigma Securities Llc owns 13,141 shares or 0.01% of their US portfolio. Moreover, Bank Of America Corp De has 0% invested in the company for 37 shares. The California-based Blackrock Fund Advisors has invested 0% in the stock. Blackrock Institutional Trust Company N.A., a California-based fund reported 33,039 shares.#img1#

BLFS Company Profile

BioLife Solutions, Inc. (BioLife), incorporated on March 25, 1998, is engaged in developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage, and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers. The Company’s product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues and organs; generic blood stem cell freezing and cell thawing media products; custom product formulation and custom packaging services; cold chain logistics services incorporating precision thermal packaging products and cloud-hosted Web applications, and contract aseptic manufacturing formulation, fill and finish services of liquid media products.

More notable recent BioLife Solutions Inc (NASDAQ:BLFS) news were published by: Prnewswire.com which released: “BioLife Solutions Reports Record Results for Third Quarter 2016” on November 10, 2016, also Prnewswire.com with their article: “BioLife Solutions to Report Third Quarter 2016 Financial Results and Provide …” published on November 03, 2016, Prnewswire.com published: “BioLife Solutions Names Cord Blood Industry Veteran Karen Foster Vice …” on April 04, 2016. More interesting news about BioLife Solutions Inc (NASDAQ:BLFS) were released by: Prnewswire.com and their article: “BioLife Solutions’ CryoStor® Embedded in Manufacturing Process for Promethera …” published on September 15, 2016 as well as Prnewswire.com‘s news article titled: “BioLife Solutions Executes 10 Year Supply Agreement with Bellicum …” with publication date: August 10, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Winifred Garcia


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>